Thrombin stimulates insulin secretion through PAR3 and blocking the cleavage of PAR3 was expected to counteract insulin resistance and β-cell failure driven by excessive insulin secretion in T2DM [65]. The gene discussed is F2RL2; the disease is Insulin resistance.